John J. Crowley

Insider Reports History

Entity
Individual
Location
251 Ballardvale Street, Wilmington, MA
Signature
/s/ Gregory Weinhoff, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John J. Crowley:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Fusion Pharmaceuticals Inc. Chief Financial Officer Common Stock 0 $0 $2.03 Jun 4, 2024 Direct
Fusion Pharmaceuticals Inc. Chief Financial Officer Restricted Stock Units 0 $0 $2.03 Jun 4, 2024 Direct
Centessa Pharmaceuticals plc Chief Financial Officer Share Option (right to buy) 600K Jul 1, 2024 Direct
Fusion Pharmaceuticals Inc. Chief Financial Officer Stock Option (Right to Buy) 0 Jun 4, 2024 Direct

Insider Reports Filed by John J. Crowley

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CNTA Centessa Pharmaceuticals plc Jul 1, 2024 1 $0 4 Jul 2, 2024 Chief Financial Officer
CNTA Centessa Pharmaceuticals plc Jun 10, 2024 0 $0 3 Jun 17, 2024 Chief Financial Officer
FUSN Fusion Pharmaceuticals Inc. Jun 4, 2024 10 $0 4 Jun 4, 2024 Chief Financial Officer
FUSN Fusion Pharmaceuticals Inc. Jan 4, 2024 2 $0 4 Jan 5, 2024 Chief Financial Officer
FUSN Fusion Pharmaceuticals Inc. Jan 5, 2023 1 $0 4 Jan 9, 2023 Chief Financial Officer
FUSN Fusion Pharmaceuticals Inc. Feb 1, 2022 2 $0 4 Feb 3, 2022 Chief Financial Officer